Carmeliet; Peter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Carmeliet; Peter.The latest application filed is for "responsiveness to angiogenesis inhibitors".

Company Profile

0.24.53

Carmeliet; Peter - Blanden N/A BE
CARMELIET; Peter - Bladen BE
Carmeliet; Peter - Landen BE
Carmeliet; Peter - Zwijnaarde BE
Carmeliet; Peter - Leuven BE
Carmeliet; Peter - Oud-Heverlee BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibition of PLGF to treat philadelphia chromosome positive leukemia Grant 10,106,601 - Carmeliet , et al. October 23, 2	2018-10-23
Responsiveness To Angiogenesis Inhibitors App 20170066822 - Carmeliet; Peter ; et al.	2017-03-09
Extracellular Allosteric Inhibitor Binding Domain From A Tyrosine Kinase Receptor App 20160193192 - Carmeliet; Peter ; et al.	2016-07-07
Carnitine Palmitoyltransferase 1 Inhibitors For Inhibition Of Pathological Angiogenesis App 20160166532 - Carmeliet; Peter ; et al.	2016-06-16
Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor Grant 9,234,025 - Carmeliet , et al. January 12, 2	2016-01-12
Responsiveness To Angiogenesis Inhibitors App 20150004136 - Carmeliet; Peter ; et al.	2015-01-01
Anti-angiogenic Therapy App 20140178397 - STASSEN; Jean-Marie ; et al.	2014-06-26
Anti-angiogenic therapy Grant 8,758,748 - Stassen , et al. June 24, 2	2014-06-24
PHD2 inhibition for blood vessel normalization, and uses thereof Grant 8,741,862 - Carmeliet , et al. June 3, 2	2014-06-03
Administering Anti-placental Growth Factor Antibodies App 20130183310 - Carmeliet; Peter ; et al.	2013-07-18
Administering Anti-placental Growth Factor Antibodies App 20130177564 - CARMELIET; Peter ; et al.	2013-07-11
Administering Anti-placental Growth Factor Antibodies App 20130177565 - CARMELIET; Peter ; et al.	2013-07-11
Induction/monitoring Of Arteriogenesis Using Sdf1 And Pdgfb Or Inhibition Of Phd2 App 20130078224 - Mazzone; Massimiliano ; et al.	2013-03-28
Administering Anti-placental Growth Factor Antibodies App 20120263710 - CARMELIET; Peter ; et al.	2012-10-18
Responsiveness To Angiogenesis Inhibitors App 20120195858 - Foernzler; Dorothee ; et al.	2012-08-02
Extracellular Allosteric Inhibitor Binding Domain From A Tyrosine Kinase Receptor App 20120094864 - Carmeliet; Peter ; et al.	2012-04-19
Phd2 Inhibition For Blood Vessel Normalization, And Uses Thereof App 20120022135 - Carmeliet; Peter ; et al.	2012-01-26
Use of VEGF and homologues to treat neuron disorders App 20110288020 - Carmeliet; Peter ; et al.	2011-11-24
Inhibition Of Plgf To Treat Philadelphia Chromosome Positive Leukemia App 20110250209 - Carmeliet; Peter ; et al.	2011-10-13
Means and methods for the recruitment and identification of stem cells Grant 8,003,096 - Carmeliet , et al. August 23, 2	2011-08-23
Anti-angiogenic Therapy App 20110123525 - Stassen; Jean-Marie ; et al.	2011-05-26
Use of VEGF and homologues to treat neuron disorders Grant 7,888,322 - Carmeliet , et al. February 15, 2	2011-02-15
Anti-PLGF antibody Grant 7,875,704 - Stassen , et al. January 25, 2	2011-01-25
Treatment of liver cirrhosis and its complications Grant 7,867,490 - Carmeliet , et al. January 11, 2	2011-01-11
Treatment of amyotrophic lateral sclerosis Grant 7,863,246 - Carmeliet January 4, 2	2011-01-04
Inhibitors of prolyl-hydroxylase-1 for the treatment of skeletal muscle degeneration Grant 7,858,593 - Carmeliet , et al. December 28, 2	2010-12-28
Means and methods for the recruitment and identification of stem cells App 20100178297 - Carmeliet; Peter ; et al.	2010-07-15
Use of placental growth factor for treating ischemic muscle disease Grant 7,727,971 - Carmeliet , et al. June 1, 2	2010-06-01
Stimulation of vascularization with VEGF-B-186 Grant 7,709,450 - Eriksson , et al. May 4, 2	2010-05-04
Treatment of amyotrophic lateral sclerosis Grant 7,687,463 - Carmeliet March 30, 2	2010-03-30
Use of VEGF and homologues to treat neuron disorders App 20100041601 - Carmeliet; Peter ; et al.	2010-02-18
Inhibitors Of Placental Growth Factor For The Treatment Of Pathological Angiogenesis, Pathological Arteriogenesis, Inflammation, Tumor Formation And/or Vascular Leakage App 20090238826 - CARMELIET; Peter ; et al.	2009-09-24
Use of VEGF and homologues to treat neuron disorders Grant 7,592,314 - Carmeliet , et al. September 22, 2	2009-09-22
Use of ppar-alpha agonists to treat skeletal muscle wasting disorders App 20090234150 - Carmeliet; Peter	2009-09-17
Inhibitors Of Placental Growth Factor For The Treatment Of Pathological Angiogenesis, Pathological Arteriogenesis, Inflammation, Tumor Formation And/or Vascular Leakage App 20090162354 - CARMELIET; Peter ; et al.	2009-06-25
Treatment of Liver Cirrhosis and Its Complications App 20090111974 - Carmeliet; Peter ; et al.	2009-04-30
Inhibitors Of Placental Growth Factor For The Treatment Of Pathological Angiogenesis, Pathological Arteriogenesis, Inflammation, Tumor Formation And/or Vascular Leakage App 20090074765 - CARMELIET; Peter ; et al.	2009-03-19
Inhibitors of prolyl-hydroxylase 1 for the treatment of skeletal muscle degeneration App 20090047294 - Carmeliet; Peter ; et al.	2009-02-19
Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage Grant 7,482,004 - Carmeliet , et al. January 27, 2	2009-01-27
Treatment of Amyotrophic Lateral Schlerosis App 20080279906 - Carmeliet; Peter	2008-11-13
Novel Anti-Plgf A Antibody App 20080193455 - Stassen; Jean-Marie ; et al.	2008-08-14
Placental growth factor as a target for the treatment of osteoporosis Grant 7,357,929 - Carmeliet , et al. April 15, 2	2008-04-15
Hypoxia inducible factor 2.alpha. for curing neonatal respiratory distress syndrome and as a target for the treatment of pulmonary hypertension Grant 7,307,060 - Compernolle , et al. December 11, 2	2007-12-11
Use of VEGF and homologues to treat neuron disorders App 20070249539 - Carmeliet; Peter ; et al.	2007-10-25
Composition and method for modulating vasculogenesis for angiogenesis App 20070172423 - Li; Xuri ; et al.	2007-07-26
Use of VEGF and homologues to treat neuron disorders Grant 7,226,908 - Carmeliet , et al. June 5, 2	2007-06-05
Transgenic amphibian models for lymphatic vessel development App 20070107072 - Carmeliet; Peter	2007-05-10
Use of placental growth factor for preventing or treating ischemic diseases or stroke App 20070027100 - Carmeliet; Peter ; et al.	2007-02-01
Means and methods for the recruitment and identification of stem cells App 20060210532 - Carmeliet; Peter ; et al.	2006-09-21
Use of hypoxia inducible factor 2 alpha for curing neonatal respiratory distress syndrome and as a target for the treatment of pulmonary hypertension App 20060205645 - Compernolle; Veerle ; et al.	2006-09-14
Method of improving ischemic muscle function by administering placental growth factor Grant 7,105,168 - Carmeliet , et al. September 12, 2	2006-09-12
Treatment of anemia App 20060183671 - Angelillo-Scherrer; Anne ; et al.	2006-08-17
Use of antibodies against FLT-1 for the treatment of osteoporosis App 20050186204 - Carmeliet, Peter ; et al.	2005-08-25
Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic disease or stroke Grant 6,930,089 - Carmeliet August 16, 2	2005-08-16
Placental growth factor as a target for the treatment of osteoporosis App 20050175609 - Carmeliet, Peter ; et al.	2005-08-11
Tissue adhesion formation control App 20050163781 - Koninckx, Philippe ; et al.	2005-07-28
Novel target to inhibit angiogenesis App 20050119198 - Carmeliet, Peter ; et al.	2005-06-02
Use of hypoxia inducible factor 2alpha for curing neonatal respiratory distress syndrome and as a target for the treatment of pulmonary hypertension App 20050043227 - Compernolle, Veerle ; et al.	2005-02-24
Method of treating atherosclerosis and other inflammatory diseases App 20040247597 - Carmeliet, Peter ; et al.	2004-12-09
VEGF-B and PDGF modulation of stem cells App 20040248796 - Alitalo, Kari ; et al.	2004-12-09
Composition and method for modulating vasculogenesis or angiogenesis App 20040053837 - Li, Xuri ; et al.	2004-03-18
Composition and method for modulating vasculogenesis or angiogenesis App 20030211994 - Li, Xuri ; et al.	2003-11-13
Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage App 20030180286 - Carmeliet, Peter ; et al.	2003-09-25
Use of inhibition of a gas6 function or of a gas6 receptor for preventing and treating a cardiovascular disease App 20030144237 - Carmeliet, Peter ; et al.	2003-07-31
Use of urokinase inhibitors for the treatment and/or prevention of pulmonary hypertension and/or cardiac remodelling App 20030125233 - Carmeliet, Peter ; et al.	2003-07-03
Use of vegf and homologues to treat neuron disorders App 20030105018 - Carmeliet, Peter ; et al.	2003-06-05
Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic disease or stroke App 20030054995 - Carmeliet, Peter	2003-03-20
Stimulation of vascularization with VEGF-B App 20030008824 - Eriksson, Ulf ; et al.	2003-01-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.